Dr. Krishna Sharan

Professor

Department of Radiotherapy Oncology

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

    • Dr. Krishna Sharan is presently the Head of the department of Radiotherapy & Oncology. He is involved in the teaching of postgraduates in Radiation Oncology, in addition to conducting classes and clinical postings on oncology classes for MBBS students.

ACADEMIC QUALIFICATIONS

Degree Specialisation Institute Year of passing
MD Radiotherapy and Oncology Kasturba Medical College, Manipal 2007
MBBS Kasturba Medical College, Mangalore March 2004

Experience

Institution / Organisation Designation Role Tenure
KMC, Manipal Professor Teaching April 2023-Till Date
KMC, Manipal Professor and Head Teaching March 2017 to March 2023
KMC Manipal Associate Professor and Head Teaching January 2015 to March 2017
KMC, Manipal Associate Professor Teaching May 2012 to June 2013
KMC, Mangalore Associate Professor Teaching july 2013 to December 2014
KMC, Manipal Assistant Professor Teaching May 2007 to May 2012

Influence of Double strand break repair on Radiation therapy induced Acute skin reactions in breast cancer patients. Int J Radiat Oncol Biol Phys 2014; 88(3):671-6.

 

Chemoradiation related acute morbidity in Carcinoma cervix and Correlation with Hematologic Toxicity: a South Indian Prospective Study. Asian Pac J Cancer Prev 2014;15(11):4483-6.

 

Clinical and microbiological profile of candida isolates from oral candidiasis in patients undergoing radiotherapy for head and neck malignancy. AJPCR 2016;9(3):1-4.

 

A qualitative study on experiences and needs of breast cancer survivors in Karnataka, India. Clin Epidemiol Glob Health 2018;6(2):69-74.

 

Patterns of Recurrence, Long-term Survival and Toxicity Analysis of Endometrial Adenocarcinoma Patients Reclassified under the Recent ESMO-ESGO-ESTRO Stratification: Seven-Year Results from a Single Institution. Int J Gynecol Cancer 2018;28: 854-60.

 

Characterizing methylation regulated miRNA in carcinoma of the human uterine cervix. Life Sciences 2019;232:116668

 

Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer. Gynec Oncol 2019;155(1):135-143

 

Prognostic role of 14q32.31 miRNA cluster in various carcinomas: a systematic review and meta‑analysis. Clin Exp Metastasis2020;37:31-46.

 

Swallowing outcomes post volumetric modulated arc therapy for head and neck cancer patients using MD Anderson dysphagia inventory: An institutional experience. International Journal of Cancer Management. 2020;13(4):e97922.

 

Triaging and adaptations of surveillance of cancer services in the COVID pandemic. Journal of Radiotherapy in Practice, 2020. DoI: https://doi.org/10.1017/S1460396920001004

 

Molecular landscape of recurrent cervical cancer. Critical Reviews in Oncology/Hematology, 2021, 157, 103178.

 

Comparison of toxicities of three weekly and weekly cisplatin in concurrent chemo-radiation for head and neck cancers: A retrospective cohort study. Onkologia I Radioterapia 2021;15(1):257–264.

 

Impact of COVID-19 on cancer care in India: a cohort study. The Lancet Oncol 2021;22(7):970–976.

Treatment outcomes after intraluminal brachytherapy following definitive chemoradiotherapy in patients with esophageal cancer. J Can Res Ther 2014; 10:337-41.

 

Detection of Human Papilloma Virus in patients with squamous cell carcinoma of the oesophagus planned for definitive chemo-radiotherapy, and a study of their clinical characteristics. J Can Res Ther 2017;13(6):1062-64.

 

Adjuvant treatment for Stage I seminoma: Why radiotherapy is better than carboplatin. J Can ResTher 2016;12:1216-9.

 

A qualitative study on experiences and needs of breast cancer survivors in Karnataka, India. Clin Epidemiol Glob Health 2018;6(2):69-74.

 

A study on the impact of patient‑related parameters in the ability to spare parotid glands by intensity‑modulated radiotherapy for head and neck squamous cell carcinomas. J Can Res Ther 2018;14:1220-4.

 

Dosimetric analysis and clinical outcomes of brachial plexus as an organ‑at‑risk in head‑and‑neck cancer patients treated with intensity‑modulated radiotherapy. J Can Res Ther 2019;15:522-7.

 

A Pilot Study on comparison of radiation Dose in Present Onco Protocol and Varied Parameters Protocol for Head and neck and Pelvic Phantom in computed Tomography. Indian Journal of Public Health Research & Development 2019;10(5):258-262.

 

Evaluating the setup uncertainties by different registration method in 3DCRT ca breast patients using onboard cone beam CT. Indian Journal of Public Health Research and Development 2019;10(11):2151-2155.

Co-authored for the “Breast Cancer Cases forecasting for Radiotherapy in Western Nepal,” Lambert Academic Publishing, 2013. ISBN: 978-3-659-37980-2.

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Interest

Breast Cancer, Head and Neck Cancer, Gynaecological cancers Paediatrics cancers, Genito-Urinary malignancies Lung cancers, CNS tumours, Soft tissue bone tumours, GIT tumours

Area of Expertise

Head and Neck malignancies, Oral and Gynaecological malignancies, Breast cancers

Area of Research

Head and Neck malignancies, Oral and Gynaecological malignancies

Professional Affiliations & Contributions

Member of Association of Radiation Oncologists of India (AROI)

Member of Indian College of Radiation Oncology (ICRO).

Member of Indian Brachytherapy Society (IBS).

Member of Society of Radiation Research (SRR)